NAIC - Instituto do Câncer

Bauru, São Paulo 17033-490

2 studies enrolling now · 2 studies all time

What they study most

Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Non-small Cell Lung Cancer

Studies at this site

• A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% — Recruiting now
• A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion — Recruiting now